{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T18:13:54Z","timestamp":1786990434192,"version":"build-2736575974"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,7,19]],"date-time":"2018-07-19T00:00:00Z","timestamp":1531958400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004243","name":"Prinses Beatrix Spierfonds","doi-asserted-by":"publisher","award":["W.OR13-21"],"award-info":[{"award-number":["W.OR13-21"]}],"id":[{"id":"10.13039\/501100004243","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004243","name":"Prinses Beatrix Spierfonds","doi-asserted-by":"publisher","award":["W.OR15-10"],"award-info":[{"award-number":["W.OR15-10"]}],"id":[{"id":"10.13039\/501100004243","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004243","name":"Prinses Beatrix Spierfonds","doi-asserted-by":"publisher","award":["W.OR16-07"],"award-info":[{"award-number":["W.OR16-07"]}],"id":[{"id":"10.13039\/501100004243","id-type":"DOI","asserted-by":"publisher"}]},{"name":"TKI-Health Holland","award":["LSHM16008"],"award-info":[{"award-number":["LSHM16008"]}]},{"name":"Tex Net"},{"name":"Sophia Foundation for Medical Research","award":["S17-32"],"award-info":[{"award-number":["S17-32"]}]},{"name":"Metakids","award":["2016-063"],"award-info":[{"award-number":["2016-063"]}]},{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007637","name":"Colciencias","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007637","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004329","name":"Genzyme Corp","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004329","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","internationaljournalofcardiology.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Cardiology"],"published-print":{"date-parts":[[2018,10]]},"DOI":"10.1016\/j.ijcard.2018.07.091","type":"journal-article","created":{"date-parts":[[2018,7,19]],"date-time":"2018-07-19T20:14:34Z","timestamp":1532031274000},"page":"104-110","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":37,"special_numbering":"C","title":["Cardiac outcome in classic infantile Pompe disease after 13\u202fyears of treatment with recombinant human acid alpha-glucosidase"],"prefix":"10.1016","volume":"269","author":[{"given":"Carine I.","family":"van Capelle","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esther","family":"Poelman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ingrid M.","family":"Frohn-Mulder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurens P.","family":"Koopman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johanna M.P.","family":"van den Hout","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luc","family":"R\u00e9gal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bjorn","family":"Cools","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wim A.","family":"Helbing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ans T.","family":"van der Ploeg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijcard.2018.07.091_bb0005","series-title":"The Metabolic and Molecular Bases of Inherited Disease","article-title":"Glycogen storage disease type II: acid alpha-glucosidase (acid maltase) deficiency","author":"Hirschhorn","year":"2001"},{"issue":"2","key":"10.1016\/j.ijcard.2018.07.091_bb0010","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1542\/peds.112.2.332","article-title":"The natural course of infantile Pompe's disease: 20 original cases compared with 133 cases from the literature","volume":"112","author":"van den Hout","year":"2003","journal-title":"Pediatrics"},{"issue":"9646","key":"10.1016\/j.ijcard.2018.07.091_bb0015","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1016\/S0140-6736(08)61555-X","article-title":"Pompe's disease","volume":"372","author":"van der Ploeg","year":"2008","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.ijcard.2018.07.091_bb0020","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/j.jpeds.2005.11.033","article-title":"A retrospective, multinational, multicenter study on the natural history of infantile-onset Pompe disease","volume":"148","author":"Kishnani","year":"2006","journal-title":"J. Pediatr."},{"issue":"5","key":"10.1016\/j.ijcard.2018.07.091_bb0025","doi-asserted-by":"crossref","first-page":"e448","DOI":"10.1542\/peds.113.5.e448","article-title":"Long-term intravenous treatment of Pompe disease with recombinant human alpha-glucosidase from milk","volume":"113","author":"Van den Hout","year":"2004","journal-title":"Pediatrics"},{"key":"10.1016\/j.ijcard.2018.07.091_bb0030","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/8904_2014_392","article-title":"Outcome of patients with classical infantile pompe disease receiving enzyme replacement therapy in Germany","volume":"20","author":"Hahn","year":"2015","journal-title":"JIMD Rep."},{"issue":"2","key":"10.1016\/j.ijcard.2018.07.091_bb0035","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1212\/01.wnl.0000251268.41188.04","article-title":"Recombinant human acid alpha-glucosidase - major clinical benefits in infantile-onset Pompe disease","volume":"68","author":"Kishnani","year":"2007","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/j.ijcard.2018.07.091_bb0040","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1007\/s10545-015-9898-5","article-title":"Response of 33 UK patients with infantile-onset Pompe disease to enzyme replacement therapy","volume":"39","author":"Broomfield","year":"2015","journal-title":"J. Inherit. Metab. Dis."},{"issue":"9","key":"10.1016\/j.ijcard.2018.07.091_bb0045","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1038\/gim.2012.44","article-title":"The emerging phenotype of long-term survivors with infantile Pompe disease","volume":"14","author":"Prater","year":"2012","journal-title":"Genet. Med."},{"issue":"5","key":"10.1016\/j.ijcard.2018.07.091_bb0050","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/j.echo.2010.03.019","article-title":"Recommendations for quantification methods during the performance of a pediatric echocardiogram: a report from the Pediatric Measurements Writing Group of the American Society of Echocardiography Pediatric and Congenital Heart Disease Council","volume":"23","author":"Lopez","year":"2010","journal-title":"J. Am. Soc. Echocardiogr."},{"key":"10.1016\/j.ijcard.2018.07.091_bb0055","series-title":"Echocardiography in Pediatric and Congenital Heart Disease","article-title":"Normal echocardiographic values for cardiovascular structures","author":"Colan","year":"2009"},{"issue":"3","key":"10.1016\/j.ijcard.2018.07.091_bb0060","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/S0735-1097(88)80061-5","article-title":"Left ventricular mass in children and adolescents","volume":"12","author":"Devereux","year":"1988","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ijcard.2018.07.091_bb0065","series-title":"Pediatric Cardiology","author":"Park","year":"2008"},{"issue":"3","key":"10.1016\/j.ijcard.2018.07.091_bb0070","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.echo.2003.12.005","article-title":"Impact of cardiac growth on Doppler tissue imaging velocities: a study in healthy children","volume":"17","author":"Eidem","year":"2004","journal-title":"J. Am. Soc. Echocardiogr."},{"issue":"17","key":"10.1016\/j.ijcard.2018.07.091_bb0075","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1016\/j.jacc.2011.07.022","article-title":"Left ventricular structural remodeling in health and disease: with special emphasis on volume, mass, and geometry","volume":"58","author":"Gaasch","year":"2011","journal-title":"J. Am. Coll. Cardiol."},{"issue":"5","key":"10.1016\/j.ijcard.2018.07.091_bb0080","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1007\/s00246-008-9235-y","article-title":"Electrocardiographic criteria for left ventricular hypertrophy in children","volume":"29","author":"Rijnbeek","year":"2008","journal-title":"Pediatr. Cardiol."},{"issue":"Suppl. 1; P-159","key":"10.1016\/j.ijcard.2018.07.091_bb0085","article-title":"New pediatric reference values for myocardial strain and strain rate using 2D speckle tracking echocardiography","volume":"24","author":"Koopman","year":"2014","journal-title":"Cardiol. Young"},{"issue":"1","key":"10.1016\/j.ijcard.2018.07.091_bb0090","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.nmd.2004.10.009","article-title":"Safety and efficacy of recombinant acid alpha-glucosidase (rhGAA) in patients with classical infantile Pompe disease: results of a phase II clinical trial","volume":"15","author":"Klinge","year":"2005","journal-title":"Neuromuscul. Disord."},{"issue":"2","key":"10.1016\/j.ijcard.2018.07.091_bb0095","first-page":"132","article-title":"Recombinant human acid alpha-glucosidase enzyme therapy for infantile glycogen storage disease type II: results of a phase I\/II clinical trial","volume":"3","author":"Amalfitano","year":"2001","journal-title":"Genet. Med."},{"issue":"1","key":"10.1016\/j.ijcard.2018.07.091_bb0100","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.jpeds.2006.02.035","article-title":"Chinese hamster ovary cell-derived recombinant human acid alpha-glucosidase in infantile-onset Pompe disease","volume":"149","author":"Kishnani","year":"2006","journal-title":"J. Pediatr."},{"issue":"4","key":"10.1016\/j.ijcard.2018.07.091_bb0105","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1016\/j.jpeds.2014.10.068","article-title":"Long-term prognosis of patients with infantile-onset Pompe disease diagnosed by newborn screening and treated since birth","volume":"166","author":"Chien","year":"2015","journal-title":"J. Pediatr."},{"issue":"Suppl. 3","key":"10.1016\/j.ijcard.2018.07.091_bb0110","doi-asserted-by":"crossref","first-page":"S333","DOI":"10.1007\/s10545-010-9179-2","article-title":"Antenatal diagnosis of pompe disease by fetal echocardiography: impact on outcome after early initiation of enzyme replacement therapy","volume":"33","author":"Hamdan","year":"2010","journal-title":"J. Inherit. Metab. Dis."},{"issue":"3","key":"10.1016\/j.ijcard.2018.07.091_bb0115","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1203\/PDR.0b013e3181b24e94","article-title":"Early treatment with alglucosidase alpha prolongs long-term survival of infants with Pompe disease","volume":"66","author":"Kishnani","year":"2009","journal-title":"Pediatr. Res."},{"issue":"6","key":"10.1016\/j.ijcard.2018.07.091_bb0120","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1007\/s00246-008-9267-3","article-title":"Cardiac remodeling after enzyme replacement therapy with acid alpha-glucosidase for infants with Pompe disease","volume":"29","author":"Levine","year":"2008","journal-title":"Pediatr. Cardiol."},{"issue":"11","key":"10.1016\/j.ijcard.2018.07.091_bb0125","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1016\/j.cardfail.2011.07.011","article-title":"Left ventricular geometry, global function, and dyssynchrony in infants and children with pompe cardiomyopathy undergoing enzyme replacement therapy","volume":"17","author":"Chen","year":"2011","journal-title":"J. Card. Fail."},{"issue":"4","key":"10.1016\/j.ijcard.2018.07.091_bb0130","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1111\/echo.13490","article-title":"Cardiac response to enzyme replacement therapy in infantile Pompe disease with severe hypertrophic cardiomyopathy","volume":"34","author":"Avula","year":"2017","journal-title":"Echocardiography"},{"issue":"1","key":"10.1016\/j.ijcard.2018.07.091_bb0135","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.ejim.2007.09.018","article-title":"Cardiomyopathy in Pompe's disease","volume":"19","author":"Fayssoil","year":"2008","journal-title":"Eur. J. Intern. Med."},{"issue":"10","key":"10.1016\/j.ijcard.2018.07.091_bb0140","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1097\/GIM.0b013e318183722f","article-title":"Arrhythmias in patients receiving enzyme replacement therapy for infantile Pompe disease","volume":"10","author":"McDowell","year":"2008","journal-title":"Genet. Med."},{"issue":"12","key":"10.1016\/j.ijcard.2018.07.091_bb0145","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1093\/europace\/eul121","article-title":"Electrophysiological study in a patient with Fabry disease and a short PQ interval","volume":"8","author":"Jastrzebski","year":"2006","journal-title":"Europace"},{"issue":"4","key":"10.1016\/j.ijcard.2018.07.091_bb0150","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1056\/NEJMoa033349","article-title":"Glycogen storage diseases presenting as hypertrophic cardiomyopathy","volume":"352","author":"Arad","year":"2005","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.ijcard.2018.07.091_bb0155","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/BF02265613","article-title":"The conduction system in Pompe's disease","volume":"2","author":"Bharati","year":"1982","journal-title":"Pediatr. Cardiol."},{"issue":"22","key":"10.1016\/j.ijcard.2018.07.091_bb0160","doi-asserted-by":"crossref","first-page":"2850","DOI":"10.1161\/01.CIR.0000075270.13497.2B","article-title":"Transgenic mice overexpressing mutant PRKAG2 define the cause of Wolff-Parkinson-White syndrome in glycogen storage cardiomyopathy","volume":"107","author":"Arad","year":"2003","journal-title":"Circulation"},{"issue":"8","key":"10.1016\/j.ijcard.2018.07.091_bb0165","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1111\/j.1460-9592.2007.02215.x","article-title":"Cardiac arrhythmias following anesthesia induction in infantile-onset Pompe disease: a case series","volume":"17","author":"Wang","year":"2007","journal-title":"Paediatr. Anaesth."},{"issue":"2","key":"10.1016\/j.ijcard.2018.07.091_bb0170","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.jpeds.2009.03.015","article-title":"Reversal of cardiac dysfunction after enzyme replacement in patients with infantile-onset Pompe disease","volume":"155","author":"Chen","year":"2009","journal-title":"J. Pediatr."}],"container-title":["International Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527318301542?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527318301542?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,31]],"date-time":"2018-10-31T17:19:49Z","timestamp":1541006389000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167527318301542"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10]]},"references-count":34,"alternative-id":["S0167527318301542"],"URL":"https:\/\/doi.org\/10.1016\/j.ijcard.2018.07.091","relation":{},"ISSN":["0167-5273"],"issn-type":[{"value":"0167-5273","type":"print"}],"subject":[],"published":{"date-parts":[[2018,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cardiac outcome in classic infantile Pompe disease after 13\u202fyears of treatment with recombinant human acid alpha-glucosidase","name":"articletitle","label":"Article Title"},{"value":"International Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijcard.2018.07.091","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}